GrowingStockReport.com

NASDAQ Gainers Watch List: Catalyst Pharmaceutical Partners Inc. (NASDAQ:CPRX) and Coronado Biosciences, Inc. (NASDAQ:CNDO) Added to Growing Stock Report's NASDAQ Gainers Watch List.

 

New York, NY -- (ReleaseWire) -- 04/22/2013 -- Growing Stock Report expands its NASDAQ Gainers Weekly Watch List adding Catalyst Pharmaceutical Partners Inc. (NASDAQ:CPRX) and Coronado Biosciences, Inc. (NASDAQ:CNDO).

Catalyst Pharmaceutical Partners Inc. (NASDAQ:CPRX) a company that operates as a development-stage specialty pharmaceutical is currently up (+15.66%) on 6,361,490 shares traded. Catalyst Pharmaceutical Partners Inc. (NASDAQ:CPRX) is currently up (+202.7%) from its recent 52-week low which has prompted Growing Stock Report to add the stock to their NASDAQ Gainers Watch List.

Click Here to find out what other Investors are saying about Catalyst Pharmaceutical Partners Inc. (NASDAQ:CPRX)

Coronado Biosciences, Inc. (NASDAQ:CNDO) a clinical stage biopharmaceutical company that focuses on the development of immunotherapy biologic agents for the treatment of autoimmune diseases and cancer is currently up (+7.38%) on 377,869 shares traded. Coronado Biosciences, Inc. (NASDAQ:CNDO) is currently up (+196.25%) from its recent 52-week low which has prompted Growing Stock Report to add the stock to their NASDAQ Gainers Watch List.

Click Here to find out what other Investors are saying about Coronado Biosciences, Inc. (NASDAQ:CNDO)

GrowingStockReport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals GrowingStockReport.com is often aware of several large investor awareness campaigns being deployed.

Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.GrowingStockReport.com

Disclosure: GrowingStockReport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit GrowingStockReport.com website, for complete risks and disclosures.

Contact Info:
Growing Stock Report
editor@GrowingStockReport.com